BridgeMD
New treatment option for Hemiplegia and/or Hemiparesis Following Stroke
Official title Immersive v/s Non-immersive Virtual Reality in Enhancing Upper Limb Functions Among Individuals With Subacute Stage Hemiplegia
ClinicalTrials.gov ID: NCT06615141
What this study is testing
- What it's testing
- The goal of this randomized controlled trial is to compare the effectiveness of immersive virtual reality combined with conventional therapy to the effectiveness of non-immersive virtual reality combined with conventional therapy in enhancing upper limb function in subacute hemiplegic stroke patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 28 to 55
You may be able to join if
- Individuals aged 28-55 years.
- Diagnosed with hemiplegia due to stroke.
- ≤ Grade 2 on Modified Ashworth scale.
- ≤ Stage 2 on Brunnstrom stages of motor recovery.
- Score of ≥ 35/36 on Cognitive assessment scale for stroke patients (CASP)
You likely can't join if
- Contraindications for VR therapy, such as severe motion sickness or photosensitive epilepsy, impaired spatial awareness.
- Pre-existing neurological conditions such as spinal cord injury, Multiple sclerosis and so affecting upper limb function.
The study team makes the final eligibility decision.
Where it's taking place
- Ajman, United Arab Emirates
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 28 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ajman, United Arab Emirates. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.